Why the study?
Does continuous bupivacaine infusion improve postoperative pain relief compared to single-shot block in patients undergoing shoulder surgery?
Does continuous bupivacaine infusion improve postoperative pain relief compared to single-shot block in patients undergoing shoulder surgery?
Answers are grounded in this paper and cite their sources.
Continuous interscalene bupivacaine infusion improves postoperative analgesia after shoulder surgery but may lead to drug accumulation and mild systemic toxicity.
Interscalene brachial plexus block was performed on 40 patients for prophylactic pain relief after shoulder surgery. A dose of 1.25 mg/kg of 0.5% bupivacaine was injected for the block (Group 1) and continued with an infusion of 0.25% bupivacaine 0.25 mg/kg/h (Group 2). If the postoperative analgesia was insufficient, the patients received i.m. oxycodone 0.15 mg/kg. In Group 1, one patient managed without oxycodone supplementation during the 24-h observation period compared with eight patients in Group 2 (P less than 0.01). The rest of the patients received 3.8 +/- 1.6 doses (Group 1) and 2.5 +/- 1.2 doses (Group 2) of oxycodone (P less than 0.05). At 30 min, the mean bupivacaine plasma concentration was 1.0 microgram/ml in Group 1 and 0.9 microgram/ml in Group 2. The mean plasma level of bupivacaine increased from 0.7 microgram/ml after 180 min to 1.1 micrograms/ml (P less than 0.01) after 24 h of infusion, providing some evidence of accumulation during infusion. The dizziness and confusion experienced by three patients could be associated with the local anaesthetic, as they obtained relief after the infusion was stopped.
No takes yet. Share an insight, caveat, or question.
Tuominen et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: